Treatment.Com International Inc. (TRUE.CN)
CAD 0.41
(-1.22%)
CAD 0.41
(-1.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | - CAD | 100.0% |
| 2022 | -377.28 Thousand CAD | 42.52% |
| 2021 | -656.4 Thousand CAD | -100.82% |
| 2020 | -326.85 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - CAD | 0.0% |
| 2024 Q1 | - CAD | 100.0% |
| 2023 Q2 | -3532.00 CAD | -93.32% |
| 2023 Q4 | -38.13 Thousand CAD | -200.0% |
| 2023 Q3 | 38.13 Thousand CAD | 1179.73% |
| 2023 FY | - CAD | 100.0% |
| 2023 Q1 | -1827.00 CAD | 82.25% |
| 2022 Q4 | -10.29 Thousand CAD | -30.75% |
| 2022 Q3 | -7872.00 CAD | 96.41% |
| 2022 Q2 | -219.35 Thousand CAD | -56.96% |
| 2022 FY | -377.28 Thousand CAD | 42.52% |
| 2022 Q1 | -139.75 Thousand CAD | 50.29% |
| 2021 Q4 | -281.16 Thousand CAD | -56.22% |
| 2021 FY | -656.4 Thousand CAD | -100.82% |
| 2021 Q3 | -179.97 Thousand CAD | -83.53% |
| 2021 Q2 | -98.06 Thousand CAD | -0.9% |
| 2021 Q1 | -97.18 Thousand CAD | -176.89% |
| 2020 Q4 | -35.1 Thousand CAD | 75.68% |
| 2020 FY | -326.85 Thousand CAD | 0.0% |
| 2020 Q3 | -144.3 Thousand CAD | -73.18% |
| 2020 Q2 | -83.32 Thousand CAD | -29.97% |
| 2020 Q1 | -64.11 Thousand CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AI/ML Innovations Inc. | 294.86 Thousand CAD | 100.0% |
| Diagnamed Holdings Corp. | - CAD | NaN% |
| Pangenomic Health Inc. | -681.43 Thousand CAD | 100.0% |
| nDatalyze Corp. | 65.2 Thousand CAD | 100.0% |
| Unidoc Health Corp. | -68.26 Thousand CAD | 100.0% |